Asthika Goonewardene Analyst PerformanceAnalyst at Leerink PartnersAsthika Goonewardene is a stock analyst at Leerink Partners in the healthcare sector, covering 19 publicly traded companies. Over the past year, Asthika Goonewardene has issued 20 stock ratings, including strong buy, buy, and hold recommendations. While full access to Asthika Goonewardene's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Asthika Goonewardene's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings42 Last 6 YearsBuy Recommendations81.08% 30 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution37RatingsDistribution of strong buy, buy, hold, and sell ratings by Asthika Goonewardene.RatingPercentageCount Strong Buy5.4%2 ratings Buy75.7%28 ratings Hold18.9%7 ratings Sell0.0%0 ratingsOut of 37 total stock ratings issued by Asthika Goonewardene at Leerink Partners, the majority (75.7%) have been Buy recommendations, followed by 18.9% Hold and 5.4% Strong Buy.Best & Worst CallsBest Call0000.0%RVMDSep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CELUOct 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ94.7% of companies on NASDAQ18 companiesNYSE5.3% of companies on NYSE1 companyAsthika Goonewardene, an analyst at Leerink Partners, currently covers 19 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare19 companies100.0%Asthika Goonewardene of Leerink Partners specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY18 companies94.7%PHARMACEUTICALS1 company5.3% Asthika Goonewardene's Ratings History at Leerink Partners Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGMABGenmab A/S10/7/2026Boost Price Target$37.21$45.00Buy$0.0000.00% ROIORICOric Pharmaceuticals10/5/2026Initiated Coverage$12.20$26.00Outperform$0.0000.00% ROIZNTLZentalis Pharmaceuticals10/5/2026Initiated Coverage$2.52$8.00Outperform$0.0000.00% ROIBNTXBioNTech3/25/2026Upgrade$88.77Strong-Buy$0.0000.00% ROILEGNLegend Biotech3/20/2026Downgrade$17.41Hold$0.0000.00% ROIBNTXBioNTech3/10/2026Set Price Target$83.89$155.00$0.0000.00% ROILEGNLegend Biotech3/10/2026Set Price Target$19.52$70.00$0.0000.00% ROILEGNLegend Biotech3/10/2026Upgrade$19.05Strong-Buy$0.0000.00% ROIACLXArcellx2/23/2026Downgrade$114.10$120.00Hold$0.0000.00% ROIACLXArcellx2/23/2026Downgrade$113.75$120.00Hold$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. EXELExelixis1/14/2026Set Price Target$44.55$51.00$0.0000.00% ROIZYMEZymeworks12/17/2025Initiated Coverage$25.85$40.00Buy$0.0000.00% ROIRCUSArcus Biosciences12/12/2025Set Price Target$22.07$30.00$0.0000.00% ROIAVBPArriVent BioPharma11/25/2025Initiated Coverage$21.51$43.00Buy$0.0000.00% ROIAVBPArriVent BioPharma11/25/2025Initiated Coverage$22.78$43.00Buy$0.0000.00% ROIGILDGilead Sciences11/24/2025Initiated Coverage$127.67$140.00Buy$0.0000.00% ROIMRSNMersana Therapeutics11/13/2025Downgrade$27.67$30.75Hold$0.0000.00% ROIGMABGenmab A/S11/6/2025Reiterated Rating$28.84$48.00Buy$0.0000.00% ROICRBUCaribou Biosciences11/4/2025Set Price Target$2.43$7.00$0.0000.00% ROIGILDGilead Sciences11/3/2025Reiterated Rating$120.58$145.00Buy$0.0000.00% ROIRCUSArcus Biosciences10/7/2025Reiterated Rating$14.54$39.00Buy$00.0000.00% ROIMRUSMerus9/29/2025Downgrade$93.81$97.00Hold$0.0000.00% ROIJANXJanux Therapeutics9/10/2025Initiated Coverage$23.78$100.00Buy$00.0000.00% ROIRVMDRevolution Medicines9/5/2025Initiated Coverage$38.95$99.00Buy$000.0000.00% ROIMRSNMersana Therapeutics8/14/2025Lower Price Target$7.65$36.00Buy$0.0000.00% ROIGILDGilead Sciences8/8/2025Upgrade$110.28$127.00Buy$000.0000.00% ROIEXELExelixis7/29/2025Lower Price Target$37.22$49.00Buy$00.0000.00% ROIEXELExelixis7/15/2025Boost Price Target$44.47$56.00Buy$00.0000.00% ROIGMABGenmab A/S7/8/2025Boost Price Target$21.33$46.00Buy$00.0000.00% ROIEXELExelixis6/23/2025Reiterated Rating$43.61$55.00Buy$00.0000.00% ROIBNTXBioNTech6/3/2025Reiterated Rating$116.20$155.00Buy$00.0000.00% ROIMRSNMersana Therapeutics5/16/2025Boost Price Target$8.33$250.00Buy$0.0000.00% ROILEGNLegend Biotech5/14/2025Lower Price Target$28.41$71.00Buy$00.0000.00% ROIALLOAllogene Therapeutics5/14/2025Lower Price Target$0.93$10.00Buy$0.0000.00% ROIGMABGenmab A/S3/11/2025Lower Price Target$20.25$45.00Buy$00.0000.00% ROIIOVAIovance Biotherapeutics3/3/2025Lower Price Target$4.09$15.00Buy$0.0000.00% ROIEXELExelixis1/27/2025Boost Price Target$32.99$43.00Buy$00.0000.00% ROIEXELExelixis1/15/2025Boost Price Target$36.78$42.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
